Back to list page

The role of SGLT inhibitors in managing CVD risk in Type 2 Diabetes


This free online webinar will benefit GPs, Nurse Prescribers, Practice Pharmacists and anyone involved in cardiovascular management

Learning Objectives

• Overview of the role of SGLT2i in managing cardiovascular risk and blood glucose in Type 2 Diabetes patients (including Blood Pressure improvement)

• Brief overview of the newly revised NICE guidance – Type 2 diabetes in adults

• Background and launch of the West Yorkshire Healthy Hearts Diabetes Treatment Guidance

• Approach to managing Cardiorenal Metabolic comorbidities

• Resources available to help PCNs including searches to identify suitable patients and information for patients

Speaker Panel

• Dr Waqas Tahir – West Yorkshire Health and Care Partnership Diabetes Clinical Lead

• Prof. Stephen Wheatcroft – Consultant Cardiologist – Leeds Teaching Hospitals NHS Trust / Professor of Cardiometabolic Medicine – University of Leeds

• Hannah Beba – Consultant Pharmacist (Diabetes) NHS Leeds CCG embedded in the Leeds GP Confederation

• Dr Rani Khatib – Consultant Pharmacist in Cardiology & Cardiovascular Research – Leeds Teaching Hospitals NHS Trust / National Clinical Champion for PCSK9i & Lipid Management – NHS England / Science Committee Member- European Society of Cardiology





Date: 26 May

Time: 12:00 - 13:00